White Raven, a CDMO specializing in formulation and aseptic filling, has chosen Cytiva for its aseptic filling needs. Cytiva’s SA25 Aseptic Filling Workcell will complete White Raven’s comprehensive drug product platform, offering flexibility to meet customers’ manufacturing and development needs.   

The SA25 Aseptic Filling Workcell is an integrated gloveless robotic isolator that eliminates the need for operation intervention. It is designed to provide an optimal aseptic process with a standardized flexible filler capable of producing vials, syringes, and cartridges with batch sizes from 100 up to 20 000 units and a fill volume range of 0.2 – 50 mL. With its closed robotic system, it reduces the risk of product contamination and can change between drug formats within 45 minutes.  

Dimitri Woronoff, CEO White Raven, said, “With Cytiva’s leadership and extensive expertise in robotic, aseptic fill-finish technology, we are poised to offer flexible and reliable aseptic filling services to innovators ranging from emerging biotech firms to established pharmaceutical players.”  

White Raven provides a range of formulation services adapted to clinical batches, with capabilities to work with mixing volumes as low as 50mL and up to 20L. The CDMO offers GMP formulation and aseptic filling of injectable drugs for preclinical, clinical and orphan drugs. To further mitigate the risk of cross-contamination, White Raven manages single-use consumables during the entire aseptic filling process.